Category: GE Healthcare
The FDA warns on new issues with GE Healthcare's neonatal warmers and resuscitation systems, which were recalled in October 2013.
Federal healthcare regulators put their highest-risk Class I label on a new warning issued over GE Healthcare's (NYSE:GE) Giraffe and Panda neonatal infant warmers and resuscitation systems.
The U.S. Federal Trade Commission OKs the $13.6 billion buyout of Life Technologies by Thermo Fisher, but not until Thermo offloads some of its businesses to GE Healthcare.
GE's healthcare segment posts modestly sinking sales while growing profits for its 4th quarter and full year 2013.
GE (NYSE:GE) subsidiary GE Healthcare this week released it's 2013 earnings, posting modest increases in profits for the 4th quarter and the full year amid relatively flat-to-declining sales.
FDA regulators assign the highest risk to GE Healthcare's recall of Multi Absorber Original Disposable anesthesia system components.
GE Healthcare offers $1.06 billion to acquire the cell culture, gene modulation and magnetic beads businesses of Thermo Fisher Scientific, which is eying a mega-deal of its own.
CareFusion closes its $500 million acquisition of Vital Signs from GE Healthcare.
CareFusion (NYSE:CFN) said it completed a deal with GE Healthcare (NYSE:GE) to acquire Vital Signs for $500 million.
Vital Signs Devices warns hospitals about a series of its disposable Multi Absorber Original anesthesia systems amid air leakage complaints.
Vital Signs Devices, a GE (NYSE:GE) Healthcare company, issued a warning for its disposable Multi Absorber Original anesthesia system after receiving complaints to a potential safety issue.